Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 2 of the 13 calendar months from Oct 2025 to Oct 2026: Aug 2026 and Sep 2026.
- Largest single sale: $5.3M (26,160 shares) of Revolution Medicines, Inc. on Aug 31, 2026. Filing
- No sale on record before this period.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Revolution Medicines, Inc. (RVMD) | Director | Jul 13, 2022 | Sep 10, 2026 |
| Cencora (COR) | Director | Oct 7, 2022 | Mar 9, 2026 |
| Moderna (MRNA) | Former Chief Financial Officer | Dec 7, 2018 | Jun 4, 2020 |
Also a director at
Recent filings
The last 4 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Sep 8, 2026, Revolution Medicines, Inc.: sold 17,090 shares for $3.6M, under a disclosed plan (some held indirectly). 1 filing: 1
- Aug 31, 2026, Revolution Medicines, Inc.: sold 56,000 shares for $11.4M, under a disclosed plan (some held indirectly). 1 filing: 1
- Jun 18, 2026, Revolution Medicines, Inc.: 1,191 shares awarded. 1 filing: 1
- Mar 5, 2026, Cencora: 557 shares granted. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.